Stockreport

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results

Traws Pharma, Inc.  (TRAW) 
PDF COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, without ritonavir, and w [Read more]